| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 117701 | 01503 | 招商局商业房托 | CWL Assets (PTC) Limited |
增持 | 1.46亿 | 14619.80万 | 12.96% | 2019-12-10 |
| 117702 | 01503 | 招商局商业房托 | Citigroup Inc. |
增持 | 2818.60万 | 7281.10万 | 6.45% | 2019-12-10 |
| 117703 | 01503 | 招商局商业房托 | EUREKA INVESTMENT COMPANY LIMITED |
增持 | 3.78亿 | 37781.95万 | 33.50% | 2019-12-10 |
| 117704 | 01503 | 招商局商业房托 | China Merchants Shekou Industrial Zone Holdings Company Limited |
增持 | 3.78亿 | 37781.95万 | 33.50% | 2019-12-10 |
| 117705 | 01503 | 招商局商业房托 | Pacific Asset Management Co., Ltd. |
增持 | 1.37亿 | 13719.20万 | 12.16% | 2019-12-10 |
| 117706 | 01503 | 招商局商业房托 | HSBC International Trustee Limited |
增持 | 1.46亿 | 14619.80万 | 12.96% | 2019-12-10 |
| 117707 | 01760 | 英恒科技 | ZENITH BENEFIT INVESTMENTS LIMITED |
增持 | 12.50万 | 5512.50万 | 5.32% | 2019-12-10 |
| 117708 | 01765 | 希教国际控股 | 成都华西希望集团有限公司 |
增持 | 4224.27万 | 418319.09万 | 62.75% | 2019-12-10 |
| 117709 | 01765 | 希教国际控股 | 四川特驱投资集团有限公司 |
增持 | 1382.49万 | 418319.09万 | 62.75% | 2019-12-10 |
| 117710 | 01765 | 希教国际控股 | 四川普华农业科技发展有限公司 |
增持 | 4224.27万 | 418319.09万 | 62.75% | 2019-12-10 |
| 117711 | 01765 | 希教国际控股 | 上海乙增企业管理有限公司 |
增持 | 1382.49万 | 418319.09万 | 62.75% | 2019-12-10 |
| 117712 | 01765 | 希教国际控股 | Tequ Group (Hong Kong) Company Limited |
增持 | 1382.49万 | 418319.09万 | 62.75% | 2019-12-10 |
| 117713 | 01765 | 希教国际控股 | China Everbright Limited |
增持 | 6144.39万 | 91430.53万 | 13.71% | 2019-12-10 |
| 117714 | 01765 | 希教国际控股 | China Everbright Holdings Company Limited |
增持 | 6144.39万 | 91430.53万 | 13.71% | 2019-12-10 |
| 117715 | 01765 | 希教国际控股 | 中国光大集团股份公司 |
增持 | 6144.39万 | 91430.53万 | 13.71% | 2019-12-10 |
| 117716 | 01765 | 希教国际控股 | Central Huijin Investment Ltd. |
增持 | 6144.39万 | 91430.53万 | 13.71% | 2019-12-10 |
| 117717 | 01801 | 信达生物 | Eight Roads Holdings Limited |
减持 | -1101.10万 | 7375.27万 | 5.86% | 2019-12-10 |
| 117718 | 01801 | 信达生物 | Impresa Management LLC |
减持 | -1473.93万 | 7160.05万 | 5.69% | 2019-12-10 |
| 117719 | 01801 | 信达生物 | Impresa Management LLC |
减持 | -461.35万 | 8633.98万 | 6.86% | 2019-12-10 |
| 117720 | 01801 | 信达生物 | Pandanus Partners L.P. |
减持 | -1101.10万 | 14306.97万 | 11.37% | 2019-12-10 |
| 117721 | 01801 | 信达生物 | Impresa Fund III Limited Partnership |
减持 | -1473.93万 | 6915.75万 | 5.50% | 2019-12-10 |
| 117722 | 01801 | 信达生物 | Pandanus Associates Inc. |
减持 | -1101.10万 | 14306.97万 | 11.37% | 2019-12-10 |
| 117723 | 01801 | 信达生物 | Impresa Fund III Limited Partnership |
减持 | -705.66万 | 8389.68万 | 6.67% | 2019-12-10 |
| 117724 | 01801 | 信达生物 | FMR LLC |
减持 | -1473.93万 | 8850.76万 | 7.04% | 2019-12-10 |
| 117725 | 01801 | 信达生物 | FIL Limited |
减持 | -1101.10万 | 14306.97万 | 11.37% | 2019-12-10 |
| 117726 | 02005 | 石四药集团 | China Pharmaceutical Company Limited |
增持 | 27.20万 | 74608.40万 | 24.59% | 2019-12-10 |
| 117727 | 02112 | 恩典生命科技 | Huarong International Financial Holdings Limited |
减持 | -7.52亿 | 0.00万 | 0.00% | 2019-12-10 |
| 117728 | 02112 | 恩典生命科技 | 华融华侨资产管理股份有限公司 |
增持 | 7.52亿 | 75200.00万 | 50.13% | 2019-12-10 |
| 117729 | 02333 | 长城汽车 | Bank of America Corporation |
增持 | 208.50万 | 15605.43万 | 5.03% | 2019-12-10 |
| 117730 | 02359 | 药明康德 | Citigroup Inc. |
减持 | -22.10万 | 831.99万 | 4.87% | 2019-12-10 |
| 117731 | 02500 | 启明医疗-B | BSPI Holdings, L.L.C. |
增持 | 2089.39万 | 2089.39万 | 12.22% | 2019-12-10 |
| 117732 | 02500 | 启明医疗-B | Ming Zhi Investments Limited |
增持 | 1678.87万 | 1678.87万 | 7.57% | 2019-12-10 |
| 117733 | 02500 | 启明医疗-B | Ming Zhi Investments (BVI) Limited |
增持 | 1678.87万 | 1678.87万 | 7.57% | 2019-12-10 |
| 117734 | 02500 | 启明医疗-B | Hillhouse Capital Advisors, Ltd. |
增持 | 1185.75万 | 1185.75万 | 6.94% | 2019-12-10 |
| 117735 | 02500 | 启明医疗-B | Gaoling Fund, L.P. |
增持 | 1185.75万 | 1185.75万 | 6.94% | 2019-12-10 |
| 117736 | 02500 | 启明医疗-B | Qiming Venture Partners III, L.P. |
增持 | 3034.25万 | 3034.25万 | 17.75% | 2019-12-10 |
| 117737 | 02500 | 启明医疗-B | Qiming GP III, L.P. |
增持 | 3034.25万 | 3034.25万 | 17.75% | 2019-12-10 |
| 117738 | 02500 | 启明医疗-B | Qiming Corporate GP III, Ltd. |
增持 | 3034.25万 | 3034.25万 | 17.75% | 2019-12-10 |
| 117739 | 02500 | 启明医疗-B | Horizon Binjiang LLC |
增持 | 4795.44万 | 4795.44万 | 21.63% | 2019-12-10 |
| 117740 | 02500 | 启明医疗-B | QM22 Limited |
增持 | 2039.68万 | 2039.68万 | 9.20% | 2019-12-10 |
| 117741 | 02500 | 启明医疗-B | QM22 (BVI) Limited |
增持 | 2039.68万 | 2039.68万 | 9.20% | 2019-12-10 |
| 117742 | 02500 | 启明医疗-B | Qiming Venture Partners III, L.P. |
增持 | 1678.87万 | 1678.87万 | 7.57% | 2019-12-10 |
| 117743 | 02500 | 启明医疗-B | Qiming Venture Partners III Annex Fund, L.P. |
增持 | 2039.68万 | 2039.68万 | 9.20% | 2019-12-10 |
| 117744 | 02500 | 启明医疗-B | Ming Zhi Investments Limited |
增持 | 3034.25万 | 3034.25万 | 17.75% | 2019-12-10 |
| 117745 | 02500 | 启明医疗-B | Broad Street Principal Investments, L.L.C. |
增持 | 2089.39万 | 2089.39万 | 12.22% | 2019-12-10 |
| 117746 | 02500 | 启明医疗-B | Broad Street Principal Investments Superholdco LLC |
增持 | 2307.69万 | 2307.69万 | 13.50% | 2019-12-10 |
| 117747 | 02500 | 启明医疗-B | Broad Street Investments Holding (Singapore) Pte. Ltd. |
增持 | 2089.39万 | 2089.39万 | 12.22% | 2019-12-10 |
| 117748 | 02500 | 启明医疗-B | The Goldman Sachs Group, Inc. |
增持 | 2307.69万 | 2307.69万 | 13.50% | 2019-12-10 |
| 117749 | 02500 | 启明医疗-B | The Goldman Sachs Group, Inc. |
增持 | 1178.05万 | 3485.74万 | 20.39% | 2019-12-10 |
| 117750 | 02500 | 启明医疗-B | Credit Suisse Group AG |
增持 | 1178.05万 | 1178.05万 | 6.89% | 2019-12-10 |